| Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization N Nakamoto, DE Kaplan, J Coleclough, Y Li, ME Valiga, M Kaminski, ... Gastroenterology 134 (7), 1927-1937. e2, 2008 | 370 | 2008 |
| Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores GN Ioannou, LA Beste, PK Green, AG Singal, EB Tapper, AK Waljee, ... Gastroenterology 157 (5), 1264-1278. e4, 2019 | 366 | 2019 |
| Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study S Kumar, DC Metz, S Ellenberg, DE Kaplan, DS Goldberg Gastroenterology 158 (3), 527-536. e7, 2020 | 265 | 2020 |
| Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality M Serper, TH Taddei, R Mehta, K D’Addeo, F Dai, A Aytaman, ... Gastroenterology 152 (8), 1954-1964, 2017 | 238 | 2017 |
| Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C DE Kaplan, K Sugimoto, K Newton, ME Valiga, F Ikeda, A Aytaman, ... Gastroenterology 132 (2), 654-666, 2007 | 216 | 2007 |
| Incidence and mortality of acute‐on‐chronic liver failure using two definitions in patients with compensated cirrhosis N Mahmud, DE Kaplan, TH Taddei, DS Goldberg Hepatology 69 (5), 2150-2163, 2019 | 192 | 2019 |
| Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans DS Goldberg, B French, KA Forde, PW Groeneveld, T Bittermann, ... Jama 311 (12), 1234-1243, 2014 | 177 | 2014 |
| Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes T Kushner, M Serper, DE Kaplan Journal of hepatology 63 (3), 586-592, 2015 | 173 | 2015 |
| A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease CA Emdin, ME Haas, AV Khera, K Aragam, M Chaffin, D Klarin, G Hindy, ... PLoS genetics 16 (4), e1008629, 2020 | 157 | 2020 |
| Risk prediction models for post‐operative mortality in patients with cirrhosis N Mahmud, Z Fricker, RA Hubbard, GN Ioannou, JD Lewis, TH Taddei, ... Hepatology 73 (1), 204-218, 2021 | 142 | 2021 |
| Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database DE Kaplan, F Dai, A Aytaman, M Baytarian, R Fox, K Hunt, A Knott, ... Clinical Gastroenterology and Hepatology 13 (13), 2333-2341. e6, 2015 | 142 | 2015 |
| Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis DS Goldberg, TH Taddei, M Serper, R Mehta, E Dieperink, A Aytaman, ... Hepatology 65 (3), 864-874, 2017 | 139 | 2017 |
| Dysfunctional B‐cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27‐Positive B‐cell population H Doi, TK Iyer, E Carpenter, H Li, KM Chang, RH Vonderheide, ... Hepatology 55 (3), 709-719, 2012 | 134 | 2012 |
| Effects of hypercholesterolemia and statin exposure on survival in a large national cohort of patients with cirrhosis DE Kaplan, MA Serper, R Mehta, R Fox, B John, A Aytaman, M Baytarian, ... Gastroenterology 156 (6), 1693-1706. e12, 2019 | 127 | 2019 |
| AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis DE Kaplan, C Ripoll, M Thiele, BE Fortune, DA Simonetto, G Garcia-Tsao, ... Hepatology 79 (5), 1180-1211, 2024 | 125 | 2024 |
| A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation M Vujkovic, S Ramdas, KM Lorenz, X Guo, R Darlay, HJ Cordell, J He, ... Nature genetics 54 (6), 761-771, 2022 | 124 | 2022 |
| Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation M Serper, EM Weinberg, JB Cohen, PP Reese, TH Taddei, DE Kaplan Hepatology 73 (1), 219-232, 2021 | 94 | 2021 |
| Starting dose of sorafenib for the treatment of hepatocellular carcinoma: a retrospective, multi-institutional study KA Reiss, S Yu, R Mamtani, R Mehta, K D’Addeo, EP Wileyto, TH Taddei, ... Journal of Clinical Oncology 35 (31), 3575-3581, 2017 | 94 | 2017 |
| Hepatitis C viraemia reversibly maintains subset of antigen‐specific T‐bet+ tissue‐like memory B cells LY Chang, Y Li, DE Kaplan Journal of viral hepatitis 24 (5), 389-396, 2017 | 94 | 2017 |
| Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular‐cholangiocarcinoma X Cai, J Zhai, DE Kaplan, Y Zhang, L Zhou, X Chen, G Qian, Q Zhao, Y Li, ... Hepatology 56 (5), 1804-1816, 2012 | 92 | 2012 |
